4.7 Article

Surface Charges and Shell Crosslinks Each Play Significant Roles in Mediating Degradation, Biofouling, Cytotoxicity and Immunotoxicity for Polyphosphoester-based Nanoparticles

期刊

SCIENTIFIC REPORTS
卷 3, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/srep03313

关键词

-

资金

  1. National Heart Lung and Blood Institute of the National Institutes of Health [HHSN268201000046C]
  2. National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01-DK082546]
  3. National Science Foundation [DMR-0906815, DMR-1105304]
  4. Welch Foundation through the W. T. Doherty-Welch Chair in Chemistry [A-0001]
  5. NIH [P30 DC004665]
  6. NHMRC
  7. David H. Koch Chair

向作者/读者索取更多资源

The construction of nanostructures from biodegradable precursors and shell/core crosslinking have been pursued as strategies to solve the problems of toxicity and limited stability, respectively. Polyphosphoester (PPE)-based micelles and crosslinked nanoparticles with non-ionic, anionic, cationic, and zwitterionic surface characteristics for potential packaging and delivery of therapeutic and diagnostic agents, were constructed using a quick and efficient synthetic strategy, and importantly, demonstrated remarkable differences in terms of cytotoxicity, immunotoxicity, and biofouling properties, as a function of their surface characteristics and also with dependence on crosslinking throughout the shell layers. For instance, crosslinking of zwitterionic micelles significantly reduced the immunotoxicity, as evidenced from the absence of secretions of any of the 23 measured cytokines from RAW 264.7 mouse macrophages treated with the nanoparticles. The micelles and their crosslinked analogs demonstrated lower cytotoxicity than several commercially-available vehicles, and their degradation products were not cytotoxic to cells at the range of the tested concentrations. PPE-nanoparticles are expected to have broad implications in clinical nanomedicine as alternative vehicles to those involved in several of the currently available medications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据